Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06077877
Title A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
GSK Investigational Site RECRUITING San Francisco California 94158 United States Details
GSK Investigational Site RECRUITING Miami Florida 33136 United States Details
GSK Investigational Site RECRUITING Saint Louis Missouri 63110 United States Details
GSK Investigational Site RECRUITING Dallas Texas 75230 United States Details
GSK Investigational Site RECRUITING Houston Texas 77030 United States Details
GSK Investigational Site RECRUITING San Antonio Texas 78229 United States Details
GSK Investigational Site RECRUITING Fairfax Virginia 22031 United States Details
GSK Investigational Site RECRUITING Edmonton Alberta T6G 1Z2 Canada Details
GSK Investigational Site RECRUITING Ottawa Ontario K1H 8L6 Canada Details
GSK Investigational Site RECRUITING Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field